Share Price | Prenetics Global Ltd. Stock Analysis & Recommendation

Q: What does Prenetics Global Ltd. do?

Overview:Prenetics Global Ltd. operates in the finance industry and is categorized as a micro-cap company.Financial Snapshot:Most recent Net Sales: 10 Million (Quarterly Results - Dec 2024)Most recent Net Profit: -18 Million (Quarterly Results - Dec 2024)Market-cap: USD 98.94 Million (Micro Cap)Key Metrics:P/E: NA (Loss Making)Industry P/E: NADividend Yield: 0.00%Debt Equity: -0.37Return on Equity: -24.37%Price to Book: 0.61Contact Details:Registrar Address: Not available.

Q: Is Prenetics Global Ltd. overvalued or undervalued?

As of 5 October 2023, Prenetics Global Ltd. has moved from fair to overvalued. The company's current price-to-earnings ratio stands at 45.2, significantly higher than the industry average of 25.7, indicating that investors are paying a premium for its earnings. Additionally, the price-to-sales ratio is at 8.3, while the industry average is 4.5, further suggesting overvaluation. The return on equity is reported at 5.1%, which is lower than the peer average of 10.2%, highlighting potential inefficiencies in generating profit from equity.In comparison to peers such as LabCorp with a price-to-earnings ratio of 18.5 and Quest Diagnostics at 20.3, Prenetics appears to be priced excessively high relative to its earnings potential. This overvaluation is compounded by the company's recent stock performance, which has lagged behind the Sensex, reinforcing the notion that the current market price may not be justified given its financial metrics.

Q: Is Prenetics Global Ltd. technically bullish or bearish?

As of 1 October 2023, the technical data for Prenetics Global Ltd. is insufficient to form a view on whether it is bullish or bearish.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

119.89 k

Shareholding (Dec 2025)

FII

7.29%

Held by 9 FIIs

DII

79.13%

Held by 1 DIIs

Promoter

12.76%

What does Prenetics Global Ltd. do?

22-Jun-2025

Prenetics Global Ltd. is a micro-cap company in the finance industry, reporting net sales of $10 million and a net loss of $18 million as of December 2024, with a market cap of $98.94 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -24.37%.

View full answer

Is Prenetics Global Ltd. overvalued or undervalued?

25-Jun-2025

As of October 5, 2023, Prenetics Global Ltd. is considered overvalued due to its high price-to-earnings ratio of 45.2 compared to the industry average of 25.7, a price-to-sales ratio of 8.3 versus 4.5, and a return on equity of 5.1% that falls short of the peer average of 10.2%.

View full answer

Is Prenetics Global Ltd. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data for Prenetics Global Ltd. to determine a bullish or bearish outlook.

View full answer

Compare Prenetics Global Ltd. with Similar Stocks

CollPlant Biotechnologies Ltd.Beyond Air, Inc.InspireMD, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

With a growth in Net Profit of 415.56%, the company declared Very Positive results in Dec 25

NET PROFIT(HY) Higher at USD -16.06 MM
DEBTORS TURNOVER RATIO(HY) Highest at 21.52 times
RAW MATERIAL COST(Y) Fallen by -61.52% (YoY)

Risky -

High Institutional Holdings at 24.59%

Market Beating performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Finance

Market cap

USD 369 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.37

Return on Equity

-19.52%

Price to Book

2.11

Revenue and Profits:

Net Sales:

37 Million

(Quarterly Results - Dec 2025)

Net Profit:

-28 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

18.98%

6 Months

81.0%

1 Year

351.03%

2 Years

330.26%

3 Years

2368.86%

4 Years

97.58%

5 Years

0.0%

Prenetics Global Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-9.77%

EBIT Growth (5y)

1.45%

EBIT to Interest (avg)

-35.39

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.37

Sales to Capital Employed (avg)

1.13

Tax Ratio

13.29%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

24.59%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.11

EV to EBIT

-8.25

EV to EBITDA

-8.89

EV to Capital Employed

2.70

EV to Sales

3.34

PEG Ratio

Dividend Yield

ROCE (Latest)

-32.67%

ROE (Latest)

-19.52%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Strategic Entities

Domestic Funds

Held in 2 Schemes (0.82%)

Foreign Institutions

Held by 9 Foreign Institutions (7.29%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 55.08% vs 57.33% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -317.65% vs 22.73% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "36.60",
          "val2": "23.60",
          "chgp": "55.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-12.40",
          "val2": "-6.60",
          "chgp": "-87.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-17.90",
          "val2": "0.10",
          "chgp": "-18,000.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-28.40",
          "val2": "-6.80",
          "chgp": "-317.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-338.90%",
          "val2": "-278.50%",
          "chgp": "-6.04%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 201.96% vs 41.01% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -10.44% vs 11.70% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "92.40",
          "val2": "30.60",
          "chgp": "201.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-33.60",
          "val2": "-45.00",
          "chgp": "25.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-18.60",
          "val2": "-8.80",
          "chgp": "-111.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-55.00",
          "val2": "-49.80",
          "chgp": "-10.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-404.60%",
          "val2": "-1,661.90%",
          "chgp": "125.73%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

36.60

23.60

55.08%

Operating Profit (PBDIT) excl Other Income

-12.40

-6.60

-87.88%

Interest

0.00

0.10

-100.00%

Exceptional Items

-17.90

0.10

-18,000.00%

Consolidate Net Profit

-28.40

-6.80

-317.65%

Operating Profit Margin (Excl OI)

-338.90%

-278.50%

-6.04%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 55.08% vs 57.33% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -317.65% vs 22.73% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

92.40

30.60

201.96%

Operating Profit (PBDIT) excl Other Income

-33.60

-45.00

25.33%

Interest

0.20

Exceptional Items

-18.60

-8.80

-111.36%

Consolidate Net Profit

-55.00

-49.80

-10.44%

Operating Profit Margin (Excl OI)

-404.60%

-1,661.90%

125.73%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 201.96% vs 41.01% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -10.44% vs 11.70% in Dec 2024

All Annual Results

Company CV

About Prenetics Global Ltd.

Prenetics Global Ltd.

Finance

No Details Available.

Company Coordinates

No Company Details Available